Non-ergot dopamine agonist-induced sleep attacks.
Two patients with Parkinson's disease received treatment with ropinirole and/or pramipexole, during which both experienced sleep attacks. These attacks may be a class effect of non-ergot dopamine agonists. Health care professionals should be aware of the potential of these agents to cause sleep attacks and caution patients about this potentially life-threatening adverse effect.
Ryan
M
M
Division of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, USA.
Slevin
J T
JT
Wells
A
A
D000368:Aged; D052160:Benzothiazoles; D018491:Dopamine Agonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D000077487:Pramipexole; D012893:Sleep Wake Disorders / Q000139:chemically induced*; D013844:Thiazoles / Q000009:adverse effects*
D052160:Benzothiazoles; D018491:Dopamine Agonists; D007211:Indoles; D013844:Thiazoles; C046649:ropinirole; D000077487:Pramipexole